TOP-GFP.mC Citations (10)
Originally described in: Differential WNT activity in colorectal cancer confers limited tumorigenic potential and is regulated by MAPK signaling.Horst D, Chen J, Morikawa T, Ogino S, Kirchner T, Shivdasani RA Cancer Res. 2012 Feb 8. PubMed Journal
Articles Citing TOP-GFP.mC
Articles |
---|
A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways. Huang T, Alvarez AA, Pangeni RP, M Horbinski C, Lu S, Kim SH, James CD, J Raizer J, A Kessler J, Brenann CW, Sulman EP, Finocchiaro G, Tan M, Nishikawa R, Lu X, Nakano I, Hu B, Cheng SY. Nat Commun. 2016 Oct 4;7:12885. doi: 10.1038/ncomms12885. PubMed |
Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins. van Andel H, Ren Z, Koopmans I, Joosten SP, Kocemba KA, de Lau W, Kersten MJ, de Bruin AM, Guikema JE, Clevers H, Spaargaren M, Pals ST. Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):376-381. doi: 10.1073/pnas.1618650114. Epub 2016 Dec 27. PubMed |
Bioengineered Submucosal Organoids for In Vitro Modeling of Colorectal Cancer. Devarasetty M, Skardal A, Cowdrick K, Marini F, Soker S. Tissue Eng Part A. 2017 Oct;23(19-20):1026-1041. doi: 10.1089/ten.tea.2017.0397. PubMed |
Syndecan-1 promotes Wnt/beta-catenin signaling in multiple myeloma by presenting Wnts and R-spondins. Ren Z, van Andel H, de Lau W, Hartholt RB, Maurice MM, Clevers H, Kersten MJ, Spaargaren M, Pals ST. Blood. 2018 Mar 1;131(9):982-994. doi: 10.1182/blood-2017-07-797050. Epub 2017 Dec 6. PubMed |
Genome-scale CRISPR-Cas9 screen of Wnt/beta-catenin signaling identifies therapeutic targets for colorectal cancer. Wan C, Mahara S, Sun C, Doan A, Chua HK, Xu D, Bian J, Li Y, Zhu D, Sooraj D, Cierpicki T, Grembecka J, Firestein R. Sci Adv. 2021 May 19;7(21). pii: 7/21/eabf2567. doi: 10.1126/sciadv.abf2567. Print 2021 May. PubMed |
FACS-based protocol to assess cytotoxicity and clonogenic potential of colorectal cancer stem cells using a Wnt/beta-catenin signaling pathway reporter. Di Franco S, Zhang L, Gaggianesi M, Lo Iacono M, Medema JP, Stassi G. STAR Protoc. 2021 Oct 19;2(4):100880. doi: 10.1016/j.xpro.2021.100880. eCollection 2021 Dec 17. PubMed |
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells. Gaggianesi M, Mangiapane LR, Modica C, Pantina VD, Porcelli G, Di Franco S, Lo Iacono M, D'Accardo C, Verona F, Pillitteri I, Turdo A, Veschi V, Brancato OR, Muratore G, Pistone G, Bongiorno MR, Todaro M, De Maria R, Stassi G. Cancers (Basel). 2022 Jan 28;14(3). pii: cancers14030673. doi: 10.3390/cancers14030673. PubMed |
Proinflammatory and Cancer-Promoting Pathobiont Fusobacterium nucleatum Directly Targets Colorectal Cancer Stem Cells. Cavallucci V, Palucci I, Fidaleo M, Mercuri A, Masi L, Emoli V, Bianchetti G, Fiori ME, Bachrach G, Scaldaferri F, Maulucci G, Delogu G, Pani G. Biomolecules. 2022 Sep 7;12(9):1256. doi: 10.3390/biom12091256. PubMed |
Non-canonical Wnt/Ca2+ signaling is essential to promote self-renewal and proliferation in colon cancer stem cells. Sarabia-Sanchez MA, Moreno-Londono AP, Castaneda-Patlan MC, Alvarado-Ortiz E, Martinez-Morales JC, Robles-Flores M. Front Oncol. 2023 Mar 10;13:1121787. doi: 10.3389/fonc.2023.1121787. eCollection 2023. PubMed |
Canonical Wnt Pathway Is Involved in Chemoresistance and Cell Cycle Arrest Induction in Colon Cancer Cell Line Spheroids. Moreno-Londono AP, Castaneda-Patlan MC, Sarabia-Sanchez MA, Macias-Silva M, Robles-Flores M. Int J Mol Sci. 2023 Mar 9;24(6):5252. doi: 10.3390/ijms24065252. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.